The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Closed Viral Vector Manufacturing Platforms Market Over The Period 2026–2030?
The market size for closed viral vector manufacturing platforms has experienced rapid expansion in recent years. This market is projected to grow from $1.96 billion in 2025 to $2.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.4%. The historical growth can be attributed to an increase in gene therapy clinical trials, greater use of viral vectors in vaccine development, the expansion of cell and gene therapy research programs, a growing regulatory focus on sterile manufacturing, and the early adoption of closed processing technologies.
The market size for closed viral vector manufacturing platforms is set to experience rapid expansion over the next few years. It is projected to achieve $3.63 billion by 2030, growing at a compound annual growth rate (CAGR) of 13.1%. This growth during the forecast period is primarily driven by the increasing commercialization of gene therapies, a rising need for large-scale viral vector supply, growing investments in advanced biomanufacturing infrastructure, the expansion of contract manufacturing capacity, and an increased focus on process standardization and automation. Prominent trends throughout the forecast period include the increasing adoption of fully closed and automated production systems, a heightened demand for scalable viral vector manufacturing platforms, the growing integration of single-use and modular components, the expansion of end-to-end closed processing workflows, and an enhanced focus on regulatory compliance and contamination control.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28981&type=smp
Which Major Factors Are Driving The Expansion Of The Closed Viral Vector Manufacturing Platforms Market?
The expansion in the number of clinical trials is projected to fuel the advancement of the closed viral vector manufacturing platforms market in the foreseeable future. These trials are meticulously planned human studies conducted to evaluate the safety, efficacy, and correct application of novel medical treatments or procedures. The escalating demand for clinical trials stems from the increasing requirement for innovative therapies, with the rising incidence of chronic and intricate diseases spurring the creation and assessment of new pharmaceuticals and treatments to meet currently unaddressed medical needs. Closed viral vector manufacturing platforms facilitate clinical trials by ensuring a uniform and sterile production of viral vectors, thereby guaranteeing the safety and dependability of the therapeutic interventions being studied. A notable example is provided by the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, which reported in December 2024 that the overall volume of industry-funded clinical trials initiated in the UK increased from 411 in 2022 to 426 in 2023. Consequently, the increasing volume of clinical trials is a primary impetus for the expansion of the closed viral vector manufacturing platforms market.
How Is The Closed Viral Vector Manufacturing Platforms Market Divided Into Its Major Segments?
The closed viral vector manufacturing platforms market covered in this report is segmented –
1) By Product Type: Plasmid Deoxyribonucleic Acid (DNA), Lentiviral Vectors, Adenoviral Vectors, Adeno-Associated Viral Vectors, Retroviral Vectors, Other Product Types
2) By Workflow: Upstream Processing, Downstream Processing, Fill-Finish
3) By Application: Gene Therapy, Vaccines, Cell Therapy, Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Manufacturing Organizations, Other End Users
Subsegments:
1) By Plasmid Deoxyribonucleic Acid (DNA): Supercoiled DNA, Linearized DNA, Minicircle DNA
2) By Lentiviral Vectors: Integrating Lentiviral Vectors, Non-Integrating Lentiviral Vectors
3) By Adenoviral Vectors: Replication-Deficient Adenoviral Vectors, Replication-Competent Adenoviral Vectors
4) By Adeno-Associated Viral Vectors (AAV): Single-Stranded AAV (ssAAV), Self-Complementary AAV (scAAV)
5) By Retroviral Vectors: Gamma-Retroviral Vectors, Alpha-Retroviral Vectors
6) By Other Product Types: Herpes Simplex Virus (HSV) Vectors, Vaccinia Virus Vectors, Baculovirus Vectors
How Are Trends Transforming The Closed Viral Vector Manufacturing Platforms Market Landscape?
Major companies within the closed viral vector manufacturing platforms market are concentrating on developing advanced solutions, such as nitro controllers, to mitigate nitrogen-induced stress or toxicity in cell cultures. Nitro controllers function as devices or systems for monitoring and regulating nitrogen levels or reactive nitrogen species in bioprocesses, thereby ensuring optimal conditions for cell growth and product formation. As an illustration, in May 2025, Univercells Technologies, a biotechnology company from Belgium, launched the scale-X nitro controller. This system is compact and economical, engineered for large-scale viral vector and vaccine production. It is compatible with 200 m² and 600 m² scale-X nitro bioreactors and accommodates both adherent and suspension cell cultures. The system supports the efficient production of AAV, lentiviral vectors, exosomes, and oncolytic viruses. Additionally, it permits rapid scale-up, enabling the transition from research and development to commercial manufacturing in just eight months.
Who Are The Prominent Organizations Shaping The Closed Viral Vector Manufacturing Platforms Market?
Major companies operating in the closed viral vector manufacturing platforms market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, WuXi AppTec, Samsung Biologics Co. Ltd., FUJIFILM Biotechnologies, Oxford Biomedica Plc, Hillgene, Takara Bio Inc., SkyPharma Production SAS, GeneScript ProBio, Obio Technology Corp. Ltd., VectorBuilder, Charles River Laboratories Pvt. Ltd., Creative Biogene, Esco Aster Pte. Ltd., Karma Biotechnologies, Cell and Gene Therapy Catapult, CoJourney, Applied Biological Laboratories Inc., CEVEC Pharmaceuticals, Genesail Biotech Co. Ltd.
Read the full closed viral vector manufacturing platforms market report here:
Which Region Currently Holds The Largest Share Of The Closed Viral Vector Manufacturing Platforms Market?
North America was the largest region in the Closed Viral Vector Manufacturing Platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed viral vector manufacturing platforms market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Closed Viral Vector Manufacturing Platforms Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28981&type=smp
Browse Through More Reports Similar to the Global Closed Viral Vector Manufacturing Platforms Market 2026, By The Business Research Company
Viral Vector Manufacturing Market Report 2026
https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report
Viral And Non Viral Vector Manufacturing Market Report 2026
Oral Expectorant Market Report 2026
https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model